Amgen, Inc. vs DigitalOcean Holdings Inc — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while DigitalOcean Holdings Inc trades at $123.32 (market cap $14.21B). The key difference: Amgen, Inc. is far larger — about 15.8× DigitalOcean Holdings Inc's market cap, and Amgen, Inc. pays a 2.43% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals.
| AMGN | DOCN | |
|---|---|---|
Market Cap | $224.14B | $14.21B |
Sector | Health | Technology |
52-Week High | $417.20 | $181.29 |
52-Week Low | $271.18 | $29.99 |
Enterprise Value | $267.45B | $14.97B |
Dividend Yield | 2.43% | — |
Trailing returns across standard periods
Latest headlines on both assets
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →